Cell membrane chromatography and its application in the analysis of bioactive ingredients of TCMs

doi:10.5246/jcps.2011.01.002

Abstract

Abstract:

Traditional Chinese medicines (TCMs) have a long history of clinical testing and reliable therapeutic efficacy. They have attracted international attention as excellent sources of bioactive compounds for the discovery of new drugs. However, TCMs usually contain hundreds or even thousands of components and only a few of these compounds are responsible for the pharmacological effects. The large number of components in TCMs makes the analysis and screening for bioactive compounds extremely difficult. Therefore, strategies for analysis and screening of bioactive compounds in TCMs have long been a focus of studies on TCMs. Cell membrane chromatography (CMC) has become a useful tool for studying the bioactive compounds of TCMs. This review summarizes the principles, characteristics, and application of CMC, and the possible problems faced when working with TCMs. This method will likely become increasingly important for screening and analysis of bioactive compounds in TCMs.

Key words: Cell membrane, Cell membrane chromatography, Screening, Bioactive ingredients, Traditional Chinese medicines

CLC Number:

R284

Supporting:

Xing-Xin Yang, Yan-Li Zhang, Xiao-Xia Zhang, Xiao-Ni Li^*. Cell membrane chromatography and its application in the analysis of
bioactive ingredients of TCMs [J]. , DOI: 10.5246/jcps.2011.01.002.

References

[1] Chen, K. Trends Pharmacol. Sci. 1995, 16, 182-187.
[2] Tsai, T.H. J. Chromatogr. B. 2001, 764, 27-48.
[3] Gong, X.D.; Sucher, N.J. Trends Pharmacol. Sci. 1999, 20, 191-196.
[4] Kaneko, K.; Taguchi, T.; Morita, H.; Yonemura, H.; Fujimoto, H.; Kawai, S. Clin. Neurophysiol. 2001, 112, 1035-1040.
[5] Yuan, R.; Lin, Y. Pharmacol. Ther. 2000, 86, 191-198.
[6] Howes, M.; Houghton, P.J. Pharmacol. Biochem. Behav. 2003, 75, 513-527.
[7] Tang, S.Y.; Whiteman, M.; Peng, Z.F. Free Radic. Biol. Med. 2004, 36, 1575-1587.
[8] Huang, X.D.; Kong, L.; Li, X.; Chen, X.G.; Guo, M.; Zou, H.F. J. Chromatogr. B. 2004, 812, 71-84.
[9] Li, P.; Qi, L.W.; Wen, X.D.; Sheng, L.H. Chin. J. Nat. Med. 2007, 5, 1-9.
[10] Zhang, Z.Q.; Zhang, Y.N.; Tian, Z.J. China J. Chin. Mater. Med. 2003, 28, 807-910.
[11] Giacomotto, J.; Segalat, L. Br. J. Pharmacol. 2010, 160, 204-216.
[12] Kulasingam, V.; Pavlou, M.P.; Diamandis, E.P. Nat. Rev. Cancer. 2010, 10, 371-378.
[13] Zhou, T.H.; Liu, G.Q. Biomedical Chromatography Progress. Beijing: Chemical Industry Publishing House. 1996, 8-10.
[14] He, L.C.; Yang, G.D.; Geng, X.D. Chin. Sci. Bull. 1999, 44, 826-831.
[15] He, L.C.; Wang, S.C.; Geng, X.D. Chromatographia. 2001, 54, 71-76.
[16] Zeng, A.G.; Yuan, B.X.; Wang, C.H.; Yang, G.D.; He, L.C. J. Chromatogr. B. 2009, 877, 1833-1837.
[17] Yuan, B.X.; Hou, J.; Yang, G.D.; Zhao, L.M.; He, L.C. Chromatographia. 2005, 619, 381-384.
[18] Wang, Y.; Yuan, B.X.; Deng, X.L.; He, L.C.; Zhang, Y.Y.; Han, Q.D. Anal. Biochem. 2005, 339, 198-205.
[19] Du, H.; He, J.Y.; Wang, S.C.; He, L.C. Anal. Bioanal. Chem. 2010, 397, 1947-1953.
[20] He, L.C.; Wang, S.C.; Yang, G.D.; Zhang, Y.M.; Wang, C.H.; Yuan, B.X.; Hou, X.F. Drug Discov. Ther. 2007, 1, 104-107.
[21] Zhao, H.R.; Yang, G.D.; He, L.C.; Yang, Y.J. Chin. Pharm. J. 2000, 35, 13-15.
[22] Liang, M.J.; He, L.C.; Yang, G.D. Life Sci. 2005, 78, 128-133.
[23] Li, Y.P.; He, L.C. Chin. Sci. Bull. 2007, 52, 922-928.
[24] Li, C.Q.; He, L.C.; Dong, H.Y.; Jin, J.Q. J. Ethnopharmacol. 2007, 114, 212-217.
[25] Wang, S.C.; Wen, B.Y.; Wang, N.; Liu, J.T.; He, L.C. Arch. Pharm. Res. 2009, 32, 521-526.
[26] Si, K.W.; Liu, J.T.; He, L.C.; Li, X.K.; Gou, W.; Liu, C.H.; Li, X.Q. J. Pharmacol. Sci. 2010, 113, 368-377.
[27] Lin, R.; Yang, G.D.; Wang, W.R.; Liu, J.T.; He, L.C.; Peng, N.; Han, C.J.; Liu, Y. J. Chin. Med. Mat. 2006, 29, 1315-1317.
[28] Meng, M.X.; Yang, Z.F.; He, L.C. Chin. J. Inf. Tradit. Chin. Med. 2008, 15, 46-47.
[29] Zhang, Y.J.; He, L.C. Chin. Pharm. J. 2005, 40, 463-465.
[30] Zhang, H.L.; Yang, G.D.; He, L.C.; Yang, Y.J. Chin. Pharm. J. 2003, 38, 92-94.
[31] Sun, M.; Ren, J.; Du, H.; Zhang, Y.M.; Zhang, J.; Wang, S.C.; He, L.C. J. Chromatogr. B. 2010, 878, 2712-2718.
[32] Wang, L.; Ren, J.; Sun, M.; Wang, S.C. J. Pharm. Biomed. Anal. 2010, 51, 1032-1036.
[33] Li, M.; Wang, S.C.; Zhang, Y.M.; He, L.C. J. Pharm. Biomed. Anal. 2010, 53, 1063-1069.
[34] Wang, S.C.; Sun, M.; Zhang, Y.M.; Du, H.; He, L.C. J. Chromatogr. A. 2010, 1217, 5246-5252.
[35] Hou, X.F.; Zhou, M.Z.; Jiang, Q.; Wang, S.C.; He, L.C. J. Chromatogr. A. 2009, 1216, 7081-7087.
[36] Wang, C.H.; He, L.C.; Wang, N.; Liu, F. J. Chromatogr. B. 2009, 877, 3019-3024.
[37] Beigi, F.; Lundahl, P. J. Chromatogr. A. 1999, 852, 313-317.
[38] Lagerguist, C.; Beigi, F. J. Pharm. Pharmacol. 2001, 53, 1437-1487.

Cell membrane chromatography and its application in the analysis of
bioactive ingredients of TCMs

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Xiaowei Chi, Qi Li, Yi Zhong, Tong Gong, Chuxiao Yi, Liangren Zhang, Zhenming Liu. Discovery of potential xanthine oxidase inhibitors based on virtual screening [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(8): 626-635.
[2]	Zhi Rao, Yuhui Wei. A cell-combining-oriented phytochemical screening strategy using triple quadrupole mass spectrometry for the investigation of potential bioactive candidates in Chinese traditional medicine preparation Xiao-ai-ping injection [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(2): 101-111.
[3]	Guifang Duan, Bo Xu, Xia Yuan, Shuxiang Song. High-throughput screening technologies for ion channel drug discovery [J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(10): 785-793.
[4]	Chennan Liu, Qian Wang, Jiangxue Han, Sihan Liu, Chunling Xiao, Yan Guan, Xinghua Li, Ying Wang, Xiao Wang, Jianzhou Meng, Maoluo Gan, Yishuang Liu. Virtual screening and high-throughput testing of L1 metallo-β-lactamase inhibitor [J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(10): 806-812.
[5]	Hua Deng, Chao Gao, Dengguo Wei, Sisi Liu. Virtual screening for triple-negative breast cancer cell inhibitors based on telomere G-quadruplex structure [J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(6): 383-389.
[6]	Jiangxue Han, Chunling Xiao, Maoluo Gan, Xinghua Li, Ying Wang, Jiayin Zheng, Dongsheng Li, Chennan Liu, Yan Guan, Jianzhou Meng, Shuchao Huang, Yishuang Liu. IMB-XH1 identified as a novel inhibitor of New Delhi metallo-β-lactamase-1 [J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(4): 238-246.
[7]	Ah-Ng Tony Kong, Siwang Yu. Cancers chemoprevention by dietary phytochemicals and traditional Chinese medicines: epigenetics and cellular signaling pathways [J]. Journal of Chinese Pharmaceutical Sciences, 2016, 25(4): 233-234.
[8]	Yishuang Liu, Jiayin Zheng, Shuchao Huang, Yan Guan, Chunling Xiao. Establishment and application of the screening model of the Mycobacterium tuberculosis β-lactamase BlaC inhibitors [J]. Journal of Chinese Pharmaceutical Sciences, 2016, 25(3): 189-195.
[9]	Xiaodan Zhang, Chen Li, Kai Zhu, Yanmeng Liu, Ruijun Wu, Jinyu Ren, Xiaomei Ling. A new method of immobilizing HEK293 cells on the inner wall of a capillary column as stationary phase for drug screening [J]. Journal of Chinese Pharmaceutical Sciences, 2016, 25(11): 821-825.
[10]	Xiwen Xue, Wenjie Zhu, Liangren Zhang, Yongjuan Zhao, Zhenming Liu. Comparison and discovery of potential non-covalent CD38 inhibitors by virtual screening strategy based on natural substrates and known inhibitors [J]. Journal of Chinese Pharmaceutical Sciences, 2015, 24(9): 572-580.
[11]	Tingbo Ding, Jibin Dong, Bin Lou, Xian-Cheng Jiang. Sphingomyelin synthase activity measurement by the fluorescent product in cell culture medium or animal plasma [J]. Journal of Chinese Pharmaceutical Sciences, 2014, 23(4): 256-261.
[12]	Yating Li, Yi Zheng, Delin Pan, Bo Xu, Yun Wu^*, Zhenjun Yang, Lihe Zhang . Development of a high-content screening method to evaluate the cellular population-based biological activity of new siRNA delivering reagent [J]. Journal of Chinese Pharmaceutical Sciences, 2013, 22(6): 467-474.
[13]	Xuan Jia, Xia Yuan, Mingming Chu, Fuxiang Ran, Runtao Li^, Jingrong Cui^. Cell cycle arrest effect of compound YSY-01A, a new proteasome inhibitor, on SK-OV-3 cells [J]. Journal of Chinese Pharmaceutical Sciences, 2013, 22(6): 483-490.
[14]	Chao Li, Ying Guo, Chao Tian, Shouxin Zhou, Rufeng Yan, Zhili Zhang, Xiaowei Wang, Junyi Liu^*. Expression, purification and activity assay of recombinant human thymidylate synthase [J]. , 2013, 22(2): 173-176.
[15]	Ping Chen, Peipei Wang, Guohua Shao, Lan Xiang^*. Acetylcholinesterase inhibitory activities of 48 traditional Chinese medicinal herbs [J]. , 2013, 22(1): 106-109.